腹腔灌注加经穴脉冲治疗仪治疗慢性盆腔炎的临床疗效

Research on Clinical Efficacy of Treatment of Chronic Pelvic Inflammatory Disease by Peritoneal Perfusion Combined with Acupoint Pulse Therapeutic Instrument

目的探讨左氧氟沙星、替硝唑、庆大霉素等药腹腔灌注加经穴脉冲治疗仪治疗慢性盆腔炎的临床疗效。方法将2011年1月～12月在我院门诊就诊的慢性盆腔炎患者400例,随机分成观察组和对照组,每组200例。观察组采用左氧氟沙星、替硝唑、庆大霉素等药腹腔灌注加经穴脉冲治疗仪治疗,对照组采用静脉注射治疗,治疗后观察其临床疗效。结果观察组治愈率为93.0%,对照组治愈率为67.5%,两组疗效比较差异有统计学意义(Z=6.4436,P<0.05);观察组和对照组的不良反应发生率分别为2.5%(5/200)和15.5%(31/200)。两组患者不良反应发生率的比较,差异有统计学意义(χ2=17.29,P<0.01)。结论应用左氧氟沙星、替硝唑、庆大霉素等药腹腔灌注加经穴脉冲治疗仪治疗慢性盆腔炎治愈率高,不良反应小,是一种安全、有效的治疗方法。

Objective To investigate the clinical efficacy of levofloxacin,tinidazole,gentamicin and other peritoneal perfusion drugs and acupoint pulse treatment instrument in the treatment of chronic pelvic inflammatory disease.Methods From January to December 2011,400 cases in our hospital for treatment of chronic pelvic inflammatory disease,were randomly divided into observation group and control group（n=200 cases）.The observation group were treated with levofloxacin,tinidazole,gentamicin and other peritoneal perfusion drugs plus acupoint pulse therapeutic equipment;the control group was given intravenous therapy.Clinical efficacy of the two groups after treatment were observed.Results The cure rate of the observation group was 93%,of the control group was 67.5%,the difference was statistically significant（Z=6.4436,P〈0.05）;side effects incidence of the observation group and control group was 2.5%（5/200）and 15.5%（31/200）respectively,with statistically significant difference（χ2=17.29,P〈0.01）.Conclusion Levofloxacin,tinidazole,gentamicin and other peritoneal perfusion drugs plus acupoint pulse therapeutic instrument treatment of chronic pelvic inflammatory disease has high cure rate and less side effects,therefore is a safe and effective treatment.